Jaguar Health, Inc. (JAGX)
Nasdaq: JAGX · Pharmaceutical Preparations · San Francisco, CA · filing with the SEC since 2013
Who owns Jaguar Health, Inc.
As filed with the SECHolders of 5% or more
3
Joshua Mailman holds 9.99% of Common Stock, par value $0.0001 per share, as its SCHEDULE 13G/A filed Sep 24, 2026 says.
Directors and officers
9
report now, of 19 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Joshua Mailman
SCHEDULE 13G/A · filed Sep 24, 2026 · Common Stock, par value $0.0001 per share · 8.4% in Jan 5, 2026
John Fife and Fredrick Waid
SCHEDULE 13G · filed Jan 29, 2025 · Common stock, Par Value $0.0001 Per Share
Iliad Research & Trading, L.P.
SCHEDULE 13G · filed Dec 11, 2025 · Common Stock, Par Value $0.0001 Per Share
Mitchell P. Kopin
SCHEDULE 13G · filed May 27, 2025 · Common stock, par value $0.0001 per share · reported falling below 5%
CVI Investments, Inc.
SCHEDULE 13G/A · filed Nov 7, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 9.9% in Aug 14, 2025
Lincoln Alternative Strategies LLC
SCHEDULE 13G/A · filed Feb 10, 2026 · Common stock, par value $0.0001 per share · reported falling below 5%, from 18.9% in Aug 29, 2025
Streeterville Capital LLC
SCHEDULE 13G/A · filed Dec 11, 2025 · Common Stock, Par Value $0.0001 Per Share · reported falling below 5%, from 6.7% in May 8, 2025
What JAGX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
JAGX Holdings
An entity · legal entity · owns, named in the 10-K filed Apr 7, 2026
Magdalena Biosciences, Inc.
An investee · investee · invested in, named in the 10-K filed Apr 7, 2026
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Apr 7, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2022 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.